Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

PYK2/FAK inhibitors reverse hypoxia-induced drug resistance in multiple myeloma.

Muz B, Buggio M, Azab F, de la Puente P, Fiala M, Padval MV, Weaver DT, Pachter JA, Vij R, Azab AK.

Haematologica. 2019 Jul;104(7):e310-e313. doi: 10.3324/haematol.2018.194688. Epub 2019 Jan 17. No abstract available.

2.

PI3K/mTOR dual inhibitor VS-5584 preferentially targets cancer stem cells.

Kolev VN, Wright QG, Vidal CM, Ring JE, Shapiro IM, Ricono J, Weaver DT, Padval MV, Pachter JA, Xu Q.

Cancer Res. 2015 Jan 15;75(2):446-55. doi: 10.1158/0008-5472.CAN-14-1223. Epub 2014 Nov 28.

3.

Combination treatment of mice with CRx-153 (nortriptyline and desloratadine) decreases the severity of experimental autoimmune encephalomyelitis.

Podojil JR, Padval MV, Miller SD.

Cell Immunol. 2011;270(2):237-50. doi: 10.1016/j.cellimm.2011.05.015. Epub 2011 May 31.

4.

Biotransformation and in vitro assessment of metabolism-associated drug-drug interaction for CRx-102, a novel combination drug candidate.

Zhang ZY, Chen M, Chen J, Padval MV, Kansra VV.

J Pharm Biomed Anal. 2009 Sep 8;50(2):200-9. doi: 10.1016/j.jpba.2009.04.013. Epub 2009 Apr 19.

PMID:
19467820
5.

Development and validation of a liquid chromatography-tandem mass spectrometry assay for the simultaneous quantitation of prednisolone and dipyridamole in human plasma and its application in a pharmacokinetic study.

Chen M, Granvil C, Ji QC, Zhang ZY, Padval MV, Kansra VV.

J Pharm Biomed Anal. 2009 Jul 12;49(5):1241-9. doi: 10.1016/j.jpba.2009.02.017. Epub 2009 Feb 25.

PMID:
19304431
6.

Liquid chromatographic determination of indapamide in the presence of its degradation products.

Padval MV, Bhargava HN.

J Pharm Biomed Anal. 1993 Oct;11(10):1033-6. No abstract available.

PMID:
8305585

Supplemental Content

Loading ...
Support Center